Skip to content

Alligator Bioscience

  •  
    • Se
  • Startpage
  • About Alligator
    • Board of Directors
    • Senior Management
    • Career
  • Research and development
    • Immunotherapy of cancer
    • Pipeline
      • Mitazalimab
      • ATOR-4066
      • ALG.APV-527
      • HLX22
    • Scientific publications
    • Scientific advisors
  • Corporate governance
    • General meeting
    • Board of Directors and Management
    • Nomination Committee
    • Audit Committee
    • Remuneration Committee
    • Remuneration
    • Auditors
    • Articles of association
    • Internal control
  • Investors
    • Share and owner information
    • Sharegraph
    • Analysts
    • Corporate deck
    • Capital raisings
      • Preferential Rights Issue Q4 2025
    • Financial reports
      • Interim reports
      • Year End Reports
      • Annual reports
    • Financial calendar
    • Presentations
  • Business Development
  • Press releases
  • Contact
  • Events

  1. Startpage
  2. Calendar
  3. List
Key downloads
Alligator Bioscience publishes Annual Report for 2025Alligator Bioscience AB reports full year financial results for 2025 and for Q4 2025 and provides a business updateBulletin from the extraordinary general meeting in Alligator Bioscience ABAlligator Bioscience AB reports financial results for Q3 2025 and provides a business updateAlligator Bioscience AB reports financial results for Q2 2025 and provides a business update
12 events found.

Events

Events Search and Views Navigation

Event Views Navigation

  • List
  • Month
  • Day
Today
  • October 2019

  • Tue 15

    Festival of Biologics, Basel

    15 October, 2019 - 17 October, 2019
    Basel , Schweiz
  • Thu 24

    Interim report July – September 2019

    24 October, 2019
  • November 2019

  • Wed 6

    SITC (Society for Immunotherapy of Cancer) 2019

    6 November, 2019 - 10 November, 2019
    National Harbor, Maryland National Harbor, Maryland, Förenta Staterna, USA

    34th Annual Meeting, National Harbor, USA

  • October 2021

  • Thu 21

    Interim report July – September 2021

    21 October, 2021
  • February 2022

  • Fri 11

    Year-end report 2021

    11 February, 2022
  • April 2022

  • Wed 27

    Interim report January – March 2022

    27 April, 2022
  • May 2022

  • Thu 5

    Annual General Meeting 2022

    5 May, 2022
  • June 2022

  • Thu 2

    Redeye Growth Day

    2 June, 2022
  • Fri 3

    ASCO Annual Meeting 2022

    3 June, 2022 - 7 June, 2022
    Chicago Chicago, Illinois, Förenta Staterna, USA
  • Wed 8

    BioStock Life Science Spring Summit

    8 June, 2022 - 9 June, 2022
  • Mon 13

    2022 BIO International Convention in San Diego

    13 June, 2022 - 16 June, 2022
    San Diego San Diego, California, Förenta Staterna, USA
  • Tue 14

    Tumor Myeloid-Directed Therapies Summit

    14 June, 2022 - 16 June, 2022
    Boston Boston, Massachusetts, Förenta Staterna, USA
  • Previous Events
  • Today
  • Next Events
  • Google Calendar
  • iCalendar
  • Outlook 365
  • Outlook Live
  • Export .ics file
  • Export Outlook .ics file
  1. Startpage
  2. Calendar
  3. List
About Alligator

Alligator, a clinical-stage biotechnology company, develops antibody-based pharmaceuticals for cancer treatment. The company specializes in the development of tumor-directed immunotherapies, in particular agonistic mono- and bispecific antibodies.

Alligator Bioscience has global headquarters in Lund, Sweden, and is listed on Nasdaq Stockholm (ticker: ATORX).

Links
  • About Alligator
  • R&D
  • Corporate governance
  • Investors
  • News
  • Business Development
  • Privacy Policy
  • Glossary
Contact us

Headquarter
Alligator Bioscience AB
Medicon Village
Scheeletorget 1
SE-223 81 Lund Sweden

Phone:
+ 46 (0)46 540 82 00

info@alligatorbioscience.com
ir@alligatorbioscience.com
bd@alligatorbioscience.com

Follow us

  

Email subscription

Subscribe to get our pressreleases and investor alerts by email from Alligator Bioscience.

Subscribe

  • © Copyright 2024 – Alligator Bioscience AB

  • Privacy Policy | Use of Cookies |  Change your cookie settings here.

  • Disclaimer Market data could be delayed. Delivered by Modular Finance.

Cookies
We use cookies for administering, monitoring and optimizing the website, and for analytical purposes, in accordance with what is stated in our cookie policy.
Settings Accept all
Cookies
Do your settings below. Or read our cookie policy.
  • Necessary
    These cookies are not optional. They are needed for the website to function.
  • Statistics
    In order for us to improve the website's functionality and structure, based on how the website is used.
  • Experience
    In order for our website to perform as well as possible during your visit. If you refuse these cookies, some functionality will disappear from the website.
  • Marketing
    By sharing your interests and behavior as you visit our site, you increase the chance of seeing personalized content and offers.
Save Accept all